Publications by authors named "Erik Schrumpf"

Claim this Profile
G
Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis.
Rudi Alberts, Elisabeth M G de Vries, Elizabeth C Goode, Xiaojun Jiang, Fotis Sampaziotis, Erik Schrumpf

Gut· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis.
Peter Fickert, Gideon M Hirschfield, Gerald Denk, Hanns-Ulrich Marschall, Istvan Altorjay, Erik Schrumpf

J Hepatol· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel serum and bile protein markers predict primary sclerosing cholangitis disease severity and prognosis.
Mette Vesterhus, Anders Holm, Johannes Roksund Hov, Ståle Nygård, Erik Schrumpf

J Hepatol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis.
Tobias J Weismüller, Palak J Trivedi, Annika Bergquist, Mohamad Imam, Henrike Lenzen, Erik Schrumpf

Gastroenterology· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls.
Martin Kummen, Kristian Holm, Jarl Andreas Anmarkrud, Ståle Nygård, Mette Vesterhus, Erik Schrumpf

Gut· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antineutrophil antibodies define clinical and genetic subgroups in primary sclerosing cholangitis.
Johannes R Hov, Kirsten M Boberg, Eli Taraldsrud, Mette Vesterhus, Maria Boyadzhieva, Erik Schrumpf

Liver Int· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surrogate endpoints for clinical trials in primary sclerosing cholangitis: Review and results from an International PSC Study Group consensus process.
Cyriel Y Ponsioen, Roger W Chapman, Olivier Chazouillères, Gideon M Hirschfield, Tom H Karlsen, Erik Schrumpf

Hepatology· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Refinement of the MHC risk map in a scandinavian primary sclerosing cholangitis population.
Sigrid Næss, Benedicte A Lie, Espen Melum, Marita Olsson, Johannes R Hov, Erik Schrumpf

PLoS One· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Indications and Outcomes in Liver Transplantation in Patients With Primary Sclerosing Cholangitis in Norway.
Ina M Andersen, Bjarte Fosby, Kirsten M Boberg, Ole P F Clausen, Peter Jebsen, Erik Schrumpf

Transplant Direct· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced liver fibrosis score predicts transplant-free survival in primary sclerosing cholangitis.
Mette Vesterhus, Johannes Roksund Hov, Anders Holm, Erik Schrumpf, Ståle Nygård

Hepatology· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary sclerosing cholangitis - the Norwegian experience.
Erik Schrumpf, Kirsten Muri Boberg, Tom H Karlsen

Scand J Gastroenterol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver transplantation in the Nordic countries - An intention to treat and post-transplant analysis from The Nordic Liver Transplant Registry 1982-2013.
Bjarte Fosby, Espen Melum, Kristian Bjøro, William Bennet, Allan Rasmussen, Erik Schrumpf

Scand J Gastroenterol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Four DNA methylation biomarkers in biliary brush samples accurately identify the presence of cholangiocarcinoma.
Kim Andresen, Kirsten Muri Boberg, Hege Marie Vedeld, Hilde Honne, Peter Jebsen, Erik Schrumpf

Hepatology· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small duct primary sclerosing cholangitis without inflammatory bowel disease is genetically different from large duct disease.
Sigrid Naess, Einar Björnsson, Jarl A Anmarkrud, Said Al Mamari, Brian D Juran, Erik Schrumpf

Liver Int· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-wide association analysis in primary sclerosing cholangitis and ulcerative colitis identifies risk loci at GPR35 and TCF4.
David Ellinghaus, Trine Folseraas, Kristian Holm, Eva Ellinghaus, Espen Melum, Erik Schrumpf

Hepatology· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver abnormalities in bowel diseases.
Martin Kummen, Erik Schrumpf, Kirsten Muri Boberg

Best Pract Res Clin Gastroenterol· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis.
Jimmy Z Liu, Johannes Roksund Hov, Trine Folseraas, Eva Ellinghaus, Simon M Rushbrook, Erik Schrumpf

Nat Genet· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunosuppression after liver transplantation for primary sclerosing cholangitis influences activity of inflammatory bowel disease.
Kristin Kaasen Jørgensen, Lina Lindström, Milada Cvancarova, Tom H Karlsen, Maria Castedal, Erik Schrumpf

Clin Gastroenterol Hepatol· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel target genes and a valid biomarker panel identified for cholangiocarcinoma.
Kim Andresen, Kirsten Muri Boberg, Hege Marie Vedeld, Hilde Honne, Merete Hektoen, Erik Schrumpf

Epigenetics· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Colorectal neoplasia in patients with primary sclerosing cholangitis undergoing liver transplantation: a Nordic multicenter study.
Kristin Kaasen Jørgensen, Lina Lindström, Milada Cvancarova, Maria Castedal, Styrbjörn Friman, Erik Schrumpf

Scand J Gastroenterol· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extended analysis of a genome-wide association study in primary sclerosing cholangitis detects multiple novel risk loci.
Trine Folseraas, Espen Melum, Philipp Rausch, Brian D Juran, Eva Ellinghaus, Erik Schrumpf

J Hepatol· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammatory bowel disease in patients with primary sclerosing cholangitis: clinical characterization in liver transplanted and nontransplanted patients.
Kristin Kaasen Jørgensen, Krzysztof Grzyb, Knut E A Lundin, Ole Petter F Clausen, Geir Aamodt, Erik Schrumpf

Inflamm Bowel Dis· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TGR5 sequence variation in primary sclerosing cholangitis.
Johannes R Hov, Verena Keitel, Erik Schrumpf, Dieter Häussinger, Tom H Karlsen

Dig Dis· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Electrostatic modifications of the human leukocyte antigen-DR P9 peptide-binding pocket and susceptibility to primary sclerosing cholangitis.
Johannes R Hov, Vasilis Kosmoliaptsis, James A Traherne, Marita Olsson, Kirsten M Boberg, Erik Schrumpf

Hepatology· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three ulcerative colitis susceptibility loci are associated with primary sclerosing cholangitis and indicate a role for IL2, REL, and CARD9.
Marcel Janse, Laetitia E Lamberts, Lude Franke, Soumya Raychaudhuri, Eva Ellinghaus, Erik Schrumpf

Hepatology· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis